Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Browsing publications by Dr Peter Stephens

Newcastle AuthorsTitleYearFull text
Dr Peter Stephens
Professor Nicola Curtin
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer2016
Dr Peter Stephens
Professor Ruth Plummer
Professor Nicola Curtin
mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition2016
Professor Ruth Plummer
Dr Nicola Cresti
Dr Yvette Drew
Dr Peter Stephens
Dr Jared Thornton
et al.
Phase 1 study of the PARP inhibitor E7449 as a single agent in patients with advanced solid tumors or B-cell lymphoma2014
Dr Jane Margetts
Dr Yvette Drew
Dr Peter Stephens
Professor Hilary Calvert
Professor Ruth Plummer
Erratum to: Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors (vol 31, pg 623, 2013 Doi: 10.1007/s10637-012-9843-5)2013
Dr Tao Chen
Dr Peter Stephens
Fiona Middleton
Professor Nicola Curtin
Targeting the S and G2 checkpoint to treat cancer2012
Dr Peter Stephens
Professor Hilary Calvert
Professor Ruth Plummer
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors2010
Dr Peter Stephens
Cancer in the older person2008